TruthArchive.ai - Related Video Feed

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and the need to understand what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker highlighted the need for further research in this area.

Speaker 0 asks: first, what impacts the loss of bifidobacterium? and second, what can we do to replenish it and keep it strong and populated? Speaker 1 responds that the microbiome is still in its infancy, and urges not to assume you can test your stools in the market because the FDA doesn’t have a test approved for testing stool. Regarding buying Bifidobacterium, he says that the problem with replenishing is you may suppress your own ability to make Bifidobacteria, and what Bifidobacteria needs is good nutrition, good vitamins, and good yogurt. He cites the case of a woman who lived to 117 years old in India, noting that remnants of bifidobacteria were found in her stools, and that she ate yogurt three times a day. When asked how much she ate, he replies that there aren’t studies on that, but yogurt is happening. Speaker 1 continues: in a world where we constantly dodge viruses, parasites, and bacteria that secrete toxins, survival involves doing one’s best. There are things that kill the microbiome, notably antibiotics. Therefore, when you take antibiotics, that’s the time to supplement with a good probiotic and good vitamins. He notes a problem: 16 out of 17 probiotics on the market do not have Bifidobacteria. He explains why he began focusing on Bifidobacteria: in the trillion-dollar probiotic industry, if you turn a bottle around and read the ingredients, the bacteria listed are Bifidobacteria. That observation during the pandemic sparked his interest in Bifidobacteria. He says the whole path is to save the Biff, referencing the idea that during stressful moments—political division, hate, anger—seeing the power of a microbe becomes important.

A study comparing autistic children to their neurotypical siblings and unrelated neurotypical children revealed that autistic children often lack bifidobacteria, a crucial microbe abundant in newborns. The speaker is publishing a paper based on this research. Identical twins with autism, who were nonverbal and aggressive, shared elevated levels of three identical microbes and had zero bifidobacteria. After treatment focused on eliminating harmful microbes and increasing beneficial ones, both twins became fully verbal and non-aggressive within seven months. The speaker believes that the microbiome offers insights into the condition of these children, as microbes travel from the gut to the brain via nerves. The speaker emphasizes the need to focus on nonverbal, severely affected autistic children and criticizes the lack of research and therapeutics, especially in light of the high number of cases in California.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage that kills off certain microbes. They also observed a lack of Bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of Bifidobacteria. They shared their personal experience of trying to increase their Bifidobacteria through kefir but finding that many products claiming to contain it did not. This led them to further research and experimentation.

Case: a kid progressed from nonverbal to speaking, then to calmer behavior as his microbiome aligned with his sister. They are publishing a paper on 20 autistic children versus 23 neurotypical siblings and six non-neurotypical kids with no family history of autism. They found autistic kids lacked a very important microbe—bifidobacteria, the microbe newborns are born with; aging is loss of bifidobacteria. In these 20 autistic children, bifidobacteria were low or absent, unlike their siblings; even within the same household, neurotypical vs autistic, those inside fared worse, indicating gut dysbiosis. In two cases of identical twins, nonverbal and aggressive, the same three microbes were elevated at baseline, and both had zero bifidobacteria. Seven months later, the twins are verbal and non-aggressive. "Follow the microbiome" to see the answer; microbes travel from gut to brain. It is a crime to ignore that. California crisis; funding should go to research and therapeutics.

"in New Jersey, the rate of autism is one in thirty three, and we we are seeing a depletion of the microbiome." "New Jersey, one in thirty three." "one in ten thousand." "What happens in thirty years from now? Is it gonna be one in one?" "will there be a child born in this country that doesn't have autism?" "the disappearing microbes that I like to call the bifidobacteria disappearance." "I I told you at the beginning, bifidobacteria is important in helping us break down sugars." "What happens when it disappears? Right?" "You're going to have increased MECFS, right? Because they're tired." "MECFS have lots of bifidobacteria."

Speaker 0: What results kind are you seeing with this study, with the fecal transplants in autistic children? We published that case supervised by the FDA: it was giving one sibling to another and the kid started verbalizing and he's not aggressive. He came to my office banging his head, breaking his teeth, and now he's responding and he's responding to treatment. He's communicating better. He's listening. He's doing classes. He's developing. Obviously, this kid was old when we got him, it's much better, we get better results and I think Doctor James Adams will tell you we get better results the younger they are. So that's one kid. We are on to more precise manipulations, kind of, with two twins that we did. We won a research award at the American College of Gastro about two weeks ago. And basically what we showed was two identical twins that had the same exact microbes at baseline. We manipulated the microbiome and then those microbes disappeared. But what we showed, which has been my path and my mission, save the Biff, is those kids, two identical twins, nine months later, their Bifidobacteria increased with whatever we did. And now they're verbalizing, they're fully reading, fully verbal. This is a beginning. The judge that judged my presentation said this is a proof of concept, right? That when you actually attain an engraftment of Bifidobacteria, these kids are improving. This is obviously my hypothesis, has been my hypothesis. To get to that, to do that, unfortunately, we do not have a stool assay right now that is valid, verified and reproducible in the consumer product, right? So this is the problem because parents are going to say, well, I gave my kids these probiotics and my kid's not improving. So what is Doctor Hazen saying? Well, the problem is if you don't see the increase in the bifidobacteria, your kid's not going to improve. And unfortunately, the tests that are out there are not valid, verified, or reproducible or anything that I could say, oh yeah, use this consumer product. We are developing a consumer product in full transparency, but we are far from that because of the fact that there are trillions of microbes in the gut. And as a responsible physician, I feel that I cannot give a report to a patient that says you have eubacteria or you have Alistope sphingoldi, but I have no idea what Alistope Spine Goldie does, if it's a good bug or a bad bug, because here's what's gonna happen. You're gonna get this lab test from me, you're gonna go to like a thousand doctors and they're gonna say, I have no idea what this test means. Which was the problem, by the way, at the beginning when all these tests were starting. Remember, UBiome, the company that sold all these tests? All these patients would get all these testing and then they would go to the GI doctor and the GI doctors would say, what is this? What the hell?

The speaker observed that patients with severe COVID were missing bifidobacteria compared to those highly exposed but uninfected. Bifidobacteria is a key microbe for immunity and is present in newborns but absent in older people. The speaker's research indicated vitamin C increases bifidobacteria, which may explain its use for treating colds. Ivermectin also increased bifidobacteria within 24 hours, possibly because it's a fermented product of a similar bacteria. The speaker hypothesized that ivermectin's observed benefits in COVID patients might be due to increased bifidobacteria. This hypothesis was the most read during the pandemic but was later retracted. The speaker believes the retraction of a hypothesis is not in the spirit of science.

The aging process is essentially a loss of bifidobacteria, and gut diversity follows a bell curve, initially increasing and then decreasing. Low diversity and low bifidobacteria are detrimental, especially in older individuals, though some rare cases show older people with high bifidobacteria levels. Those older patients with high bifidobacteria were much healthier. Retaining bifidobacteria could be a key factor for longevity, hence the hashtag "save the biff." The goal is to develop a protocol to maintain bifidobacteria throughout life to achieve the best health outcomes. The hypothesis is that the longer you retain your bifidobacteria, the longer you can live.

"When fecal transplant showed more than, you know, improving C." "And one of my patients with Alzheimer's started remembering his daughter's date of birth, I said, what did I do? I just changed the microbiome." "I used the wife's microbiome to the husband." "It wasn't about pushing stools for Alzheimer's, but what was causing Alzheimer's? What microbes was the culprit?" "What microbes could suppress that microbe That's the culprit." "Babies have a lot of bifidobacteria, this important microbe that helps us decompose sugar." "And we saw a lot of Bifidobacteria in newborns." "There is obviously a consensus in the medical field because there's a lot of gynecologists now that are using the secretions from the vagina of the mom and smearing it on the baby that is born with C section to just make them healthier in a way."

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also discovered that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

"everybody is different." "We all have a fingerprint of our microbiome." "families are different." "the mom with triplets had an overgrowth of a certain group of microbes and the triplets, two of the triplets didn't have that microbe, but the one with autism had twice the amount of microbes that the mom had." "Engraftment determines success of a fecal transplant." "The kid started speaking, verbalizing." "We discovered that those people that had severe COVID had zero Bifidobacteria." "autistic kids have loss of bifidobacteria." "two identical twins, same exact microbes disappeared after nine months, and the Bifidobacteria goes up." "these kids are verbalizing, they're reading, they're counting." "Restoring the microbiome, saving the Bif, improving the bifidobacteria, and the kids are verbalizing." "this is a new revelation." "And I think it's going to be one of the biggest discoveries of this century in my opinion."

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that some products claiming to contain bifidobacteria did not actually have it. Research is ongoing to further explore these findings.

Out of a thousand samples analyzed in the last year, less than 5% had bifidobacteria, and one out of a thousand stool samples had lactobacillus. Both are believed to be very important microbes. The speaker poses the question of what happens when Bifidobacteria and lactobacillus disappear. They claim you can't absorb sugar or calcium, and asks what happens to the Krebs cycle and humanity. They suggest the loss of bifida bacteria may be linked to chronic disease.

In December 2020, the speaker began collecting stool samples from colleagues before and after their COVID vaccination to study the vaccine's impact on the microbiome. The speaker discovered that mRNA vaccines killed bifidobacteria but believed these findings were unpublishable due to the prevailing narrative. The speaker presented this research as an abstract at the American College of Gastroenterology in October 2022, where it won a research award, beating 6,000 other abstracts. This abstract drew the attention of 18,000 GI doctors, who began to consider that the loss of bifidobacteria may explain why they contracted COVID after vaccination. Further research indicated persistent damage to bifidobacteria from the vaccine. The speaker's presentation also linked the loss of bifidobacteria to Crohn's disease, Lyme disease, and invasive cancer.

Speaker 0 and Speaker 1 describe findings from studying COVID and the gut microbiome, focusing on bifidobacteria. They state that their lab was the one to detect COVID in stool samples. Their central questions were what COVID does to the microbiome and how long the virus remains in the gut. They observed that one patient had COVID for up to 45 days after respiratory symptoms resolved, and another case showed the virus detectable for up to a year and a half after respiratory symptoms ended. This led them to investigate differences between people who do and do not get COVID, including households with similar exposures. A key observation was linked to bifidobacteria. They note that a difference between individuals who stayed healthy and those who contracted COVID was the level of bifidobacteria. They point out that bifidobacteria are the bacteria commonly advertised as probiotics, present in newborns and that aging is associated with its decline. They emphasize bifidobacteria as an important microbe for the microbiome and its potential role in health outcomes. The discussion includes an example: a farmer who kissed his COVID-positive wife and did not get COVID himself had high microbial diversity and a good amount of bifidobacteria, suggesting resilience due to microbial composition, including bifidobacteria. They extend the implication to mental health, noting that loss of bifidobacteria has been observed in anxiety and bipolar disorder, while acknowledging this is not the only microbe involved in those conditions. Another function attributed to bifidobacteria is aiding digestion: they help break down food to release sugars that enter cells, and assist in releasing calcium. The speakers contrast this with the broader focus on mitochondria and mitochondrial function, arguing that gut microbes initiate the process by breaking down food in the bowels to supply sugars and calcium for cellular processes. In summary, their findings indicate that people with higher bifidobacteria are more resilient to COVID and healthier, whereas those with lower bifidobacteria correlate with greater vulnerability; bifidobacteria play a role in sugar absorption, calcium release, and overall metabolic and potentially mental health outcomes. Speaker 1 and Speaker 0 confirm: people with more bifidobacteria were more resilient and did not get sick from COVID, while those who got very sick did not have enough bifidobacteria or had low levels.

Bifidobacteria is presented as a common denominator lacking in individuals with autism, Alzheimer's, cancer, anxiety, bipolar disorder, obesity, and diabetes. The speaker questioned why young people were less affected by COVID-19 compared to older, diabetic, or obese individuals, and also why some seemingly healthy individuals with autoimmune conditions were severely affected. The speaker had pre-pandemic microbiome data and observed a correlation between bifidobacteria levels and COVID-19 outcomes. High-risk individuals exposed to COVID-19 who never contracted the virus had high levels of bifidobacteria, while those who contracted the virus multiple times had zero bifidobacteria. This observation reinforced the importance of bifidobacteria, further emphasized by treatment outcomes.

The speaker highlights a widespread loss of Bifidobacteria across conditions. "Lyme disease had zero bifidobacteria." "Crohn's patients, zero bifidobacteria." "Alzheimer's patients, zero bifidobacteria." "Invasive cancer, zero bifidobacteria." When we compare to non invasive cancer, long COVID, zero bifidobacteria. "Bipolar disorder. We talk about mental health, right? Zero bifida bacteria, anxiety." The speaker notes: "Think about all the people that were so anxious during COVID. It was through the roof." It is suggested: "Is it because they killed their bifidobacteria, got the virus, and therefore, the bacteroides went up and caused that anxiety." The closing point: "So, the world of the microbiome really opened up during the pandemic."

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the Bifidobacteria, an important microbe, decreased in patients before and after vaccination. This led them to believe that the vaccine may be creating a bacteriophage or bifidophage that kills off certain microbes. They also noticed a lack of bifidobacteria in newborns born to vaccinated mothers, which could potentially be linked to conditions like autism. The speaker emphasized the importance of studying the microbiome in various diseases and highlighted the need to investigate what is causing the loss of bifidobacteria. They conducted their own research and discovered that many products claiming to contain bifidobacteria actually did not. Overall, the speaker emphasized the importance of research in understanding and addressing these issues.

According to the speaker, Albert Einstein said humanity would only have four years to live if all the bees were destroyed. The speaker believes humanity will only have four years to live if bifidobacteria are destroyed, and claims we are close to that point. The speaker states that after analyzing a thousand stool samples with deep genetic sequencing, bifidobacteria are present in less than five percent of people. The speaker further claims that out of those thousand samples, only about twenty had bifidobacteria present above ten percent, which the speaker finds alarming.

Out of a thousand samples analyzed in the last year, less than 5% had bifidobacteria, and one out of a thousand stool samples had lactobacillus. Both are considered very important microbes. The speaker asks what happens when Bifidobacteria and lactobacillus disappear, claiming that you can't absorb sugar or calcium, and questioning what happens to the Krebs cycle and humanity. The speaker suggests that the loss of bifida bacteria may be linked to chronic disease.

Speaker 0: Bifidobacteria was absent in kids with autism, that Bifidobacteria was absent in Alzheimer's. Bifidobacteria was absent in long haulers, vaccine injured, Lyme patients, Crohn's patients, invasive cancer. When you look at who has Bifidobacteria, the newborns have a lot of Bifidobacteria, old people have zero Bifidobacteria. Nursing home dying, zero Bifidobacteria. The process of aging is really this loss of Bifidobacteria. Expanded: if you look at and you believe the Bible, you know, people lived a lot longer. In biblical times than we are right now. We're barely making it to seventy, eighty and not really healthy seventy, eighty. You know, the mind starts going. So, is the mind starting to go because of the loss of Bifidobacteria? And, when you start looking at, well, what improves Bifidobacteria, right? So, our lab discovered vitamin C improves Bifidobacteria. Okay. Our lab discovered bovine immunoglobulins, the blood of the cow spun around that clear stuff, provided that the cow is not on a lot of antibiotics, is not given a lot of hormones, is not given like thousands of vaccines. So when you start looking at all that, you start seeing the importance of Bifidobacteria and you start seeing, like even me, you know, with Progena Biome, looking at the stool samples before the pandemic, during the pandemic and after the pandemic, there is a lot of disappearance of Bifidobacteria. Is that why we're having an increase in Alzheimer's, increase in cancer? Have we demolished this bifidobacteria? So, to me, that's a very important microbe that I believe is our longevity, if we can retain it. And it's not easy to retain in a world that's toxic in a way and in a world where we are, you know, put you know, given media full of stress, where we are divided, where we are, you know, constantly nervous of the next pandemic or the next virus, you know, it's it's almost like this bottle that you're shaking and it's full of gas and you just need to put it on the counter and let it just calm down, right? So, I think that's, it's a very important microbe.

The speaker discusses striking clinical observations linking the microbiome, specifically Bifidobacteria, to major improvements in two areas: autism and cancer. They reference two twins with autism who were nonverbal. After improving and manipulating their microbiome, the twins are described as completely fully verbal and reading books, highlighting the potential power of Bifidobacteria in their treatment approach. The speaker then shifts to oncology, noting they recently finished speaking at the Win Consortium in front of academic oncologists. They presented data on a patient with stage four head and neck cancer who “shrunk by increasing the bifidobacteria,” emphasizing that the observed tumor response was attributed to the microbiome rather than surgery, chemotherapy, or radiation. This observation is described as illustrating “the power of the bifidobacteria.” Following this, the speaker describes how these findings are opening new collaborations with major cancer centers, specifically naming Penn State and MD Anderson, as oncologists recognize that while immunotherapy is being given, there is interest in long-term outcomes and better survival. The implication is that there may be an element being missed related to the microbiome. Finally, the speaker mentions ongoing research on neuroblastoma, focusing on Bifidobacteria and the broader microbiome to determine how immunotherapy can help on one side and how boosting the microbiome can help on the other. The overarching message is that “we tend to forget about the microbiome and immunity starts in the gut,” suggesting a central role for the gut microbiome in modulating immune responses and therapeutic outcomes.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed a lack of bifidobacteria in newborns born to vaccinated mothers, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.